The CHRNA5–A3–B4 Gene Cluster and Smoking: From Discovery to Therapeutics

Genome-wide association studies (GWASs) have identified associations between the CHRNA5–CHRNA3–CHRNB4 gene cluster and smoking heaviness and nicotine dependence. Studies in rodents have described the anatomical localisation and function of the nicotinic acetylcholine receptors (nAChRs) formed by the subunits encoded by this gene cluster. Further investigations that complemented these studies highlighted the variability of individuals’ smoking behaviours and their ability to adjust nicotine intake. GWASs of smoking-related health outcomes have also identified this signal in the CHRNA5–CHRNA3–CHRNB4 gene cluster. This insight underpins approaches to strengthen causal inference in observational data. Combining genetic and mechanistic studies of nicotine dependence and smoking heaviness may reveal novel targets for medication development. Validated targets can inform genetic therapeutic interventions for smoking cessation and tobacco-related diseases.

[1]  A. C. Collins,et al.  Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization , 2004, Science.

[2]  Paul C. D. Johnson,et al.  Association Between Genetic Variants on Chromosome 15q25 Locus and Objective Measures of Tobacco Exposure , 2012, Journal of the National Cancer Institute.

[3]  M. Munafo,et al.  Genetics: Finding Genes for Schizophrenia , 2014, Current Biology.

[4]  K. Kendler,et al.  Smoking and schizophrenia in population cohorts of Swedish women and men: a prospective co-relative control study. , 2015, The American journal of psychiatry.

[5]  M. Munafo,et al.  G = E: What GWAS Can Tell Us about the Environment , 2016, PLoS genetics.

[6]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[7]  W. Velicer,et al.  Biochemical verification of tobacco use and cessation. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[8]  B. Heckman,et al.  Variation in the Alpha 5 Nicotinic Acetylcholine Receptor Subunit Gene Predicts Cigarette Smoking Intensity as a Function of Nicotine Content , 2013, The Pharmacogenomics Journal.

[9]  J. Warner,et al.  Role of α5 Nicotinic Acetylcholine Receptors in Pharmacological and Behavioral Effects of Nicotine in Mice , 2010, Journal of Pharmacology and Experimental Therapeutics.

[10]  U. Maskos,et al.  Aversion to Nicotine Is Regulated by the Balanced Activity of β4 and α5 Nicotinic Receptor Subunits in the Medial Habenula , 2011, Neuron.

[11]  N. Timpson,et al.  BMI as a Modifiable Risk Factor for Type 2 Diabetes: Refining and Understanding Causal Estimates Using Mendelian Randomization , 2016, Diabetes.

[12]  R. Murray,et al.  Does tobacco use cause psychosis? Systematic review and meta-analysis , 2015, The lancet. Psychiatry.

[13]  T. Spector,et al.  Genome-Wide Meta-Analysis of Cotinine Levels in Cigarette Smokers Identifies Locus at 4q13.2 , 2016, Scientific Reports.

[14]  Daniel F. Gudbjartsson,et al.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.

[15]  C. Lerman,et al.  Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio , 2016, Journal of Neuroimmune Pharmacology.

[16]  P. Romundstad,et al.  Causal associations of tobacco smoking with cardiovascular risk factors: a Mendelian randomization analysis of the HUNT Study in Norway. , 2014, International journal of epidemiology.

[17]  Joel Gelernter,et al.  A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans , 2015, Neuropsychopharmacology.

[18]  William Wheeler,et al.  Multiple Independent Loci at Chromosome 15q25.1 Affect Smoking Quantity: a Meta-Analysis and Comparison with Lung Cancer and COPD , 2010, PLoS genetics.

[19]  Blair H. Smith,et al.  Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium , 2015, BMJ Open.

[20]  M. Levine,et al.  Optimal Carbon Monoxide Criteria to Confirm Smoking Status Among Postpartum Women. , 2016, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[21]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[22]  A. Fanous,et al.  Variants in the 15q25 gene cluster are associated with risk for schizophrenia and bipolar disorder , 2013, Psychiatric genetics.

[23]  Blair H. Smith,et al.  Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in the CARTA Consortium. , 2015, Circulation. Cardiovascular genetics.

[24]  Paolo Vineis,et al.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.

[25]  G. Davey Smith,et al.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.

[26]  D. Bertrand,et al.  Nicotinic acetylcholine receptors: from basic science to therapeutics. , 2013, Pharmacology & therapeutics.

[27]  Y. Shaham,et al.  The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys , 2015, Biological Psychiatry.

[28]  Ricardo Araya,et al.  Smoking Is Associated with, but Does Not Cause, Depressed Mood in Pregnancy – A Mendelian Randomization Study , 2011, PloS one.

[29]  M. Munafo,et al.  Rethinking the association between smoking and schizophrenia. , 2015, The lancet. Psychiatry.

[30]  V. Chefer,et al.  Dynorphin and the pathophysiology of drug addiction. , 2007, Pharmacology & therapeutics.

[31]  P. Muglia,et al.  α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking , 2008, Molecular Psychiatry.

[32]  L. Peltonen,et al.  Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15. , 2009, Human molecular genetics.

[33]  M. Munafo,et al.  Determining the Causes and Consequences of Nicotine Dependence: Emerging Genetic Research Methods , 2014, Current Psychiatry Reports.

[34]  C. D. Fowler,et al.  Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability , 2014, Neuropharmacology.

[35]  Shah Ebrahim,et al.  Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index , 2011, International journal of epidemiology.

[36]  T. Spector,et al.  Genetic Relationship between Schizophrenia and Nicotine Dependence , 2016, Scientific Reports.

[37]  M. Fluharty,et al.  Correction. Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. , 2015, BMJ open.

[38]  P. Griffin,et al.  Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions. , 2012, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[39]  W. Berrettini,et al.  The CHRNA5–A3–B4 gene cluster in nicotine addiction , 2012, Molecular Psychiatry.

[40]  Angelita Pui-Yee Wong,et al.  Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium , 2014, BMJ Open.

[41]  Ming D. Li,et al.  Genome-wide meta-analyses identify multiple loci associated with smoking behavior , 2010, Nature Genetics.

[42]  M. Munafo,et al.  Smoking as a causal risk factor for schizophrenia. , 2015, The lancet. Psychiatry.

[43]  W. Berrettini,et al.  Acetylcholine Receptor (AChR) α5 Subunit Variant Associated with Risk for Nicotine Dependence and Lung Cancer Reduces (α4β2)2α5 AChR Function , 2011, Molecular Pharmacology.

[44]  S. Bojesen,et al.  High tobacco consumption is causally associated with increased all-cause mortality in a general population sample of 55,568 individuals, but not with short telomeres: a Mendelian randomization study. , 2014, International journal of epidemiology.

[45]  Tatiana Foroud,et al.  Variants in nicotinic receptors and risk for nicotine dependence. , 2008, The American journal of psychiatry.

[46]  Paul C. D. Johnson,et al.  Genetic variation in the 15q25 nicotinic acetylcholine receptor gene cluster (CHRNA5–CHRNA3–CHRNB4) interacts with maternal self-reported smoking status during pregnancy to influence birth weight , 2012, Human molecular genetics.

[47]  J. Changeux,et al.  Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine , 1998, Nature.

[48]  S. Ebrahim,et al.  Mendelian randomization: prospects, potentials, and limitations. , 2004, International journal of epidemiology.

[49]  K. Fagerström.  Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. , 2012, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[50]  Marcus R Munafò,et al.  A recall-by-genotype study of CHRNA5-A3-B4 genotype, cotinine and smoking topography: study protocol , 2014, BMC Medical Genetics.

[51]  L. Hawk,et al.  Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking , 2015, PloS one.

[52]  Line Rode,et al.  High tobacco consumption lowers body weight: a Mendelian randomization study of the Copenhagen General Population Study. , 2015, International journal of epidemiology.

[53]  C. D. Fowler,et al.  Habenular α5* nicotinic receptor signaling controls nicotine intake , 2011, Nature.

[54]  Megan E. Piper,et al.  Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation. , 2015, Drug and alcohol dependence.

[55]  Qun Lu,et al.  Habenular a5 nicotinic receptor subunit signalling controls nicotine intake , 2011 .

[56]  P. Lichtenstein,et al.  Critical need for family-based, quasi-experimental designs in integrating genetic and social science research. , 2013, American journal of public health.

[57]  B. Nordestgaard,et al.  Tobacco smoking is causally associated with antipsychotic medication use and schizophrenia, but not with antidepressant medication use or depression. , 2015, International journal of epidemiology.

[58]  Nicholas G Martin,et al.  Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. , 2007, Human molecular genetics.